De Anti-HCV Sneltest is een colloidal gold immunochromatografische assay voor de kwalitatitieve bepaling van antilichamen tegen het Hepatitis C Virus (HCV) in humane bloed samples (veneus bloed vanuit vingerprik), serum of plasma. De test is bedoeld voor professioneel gebruik.
The High Risk HPV Genotyping Kit (Abbreviation: Sanity 2.0 hrHPV) is a qualitative in vitro test used for HPV genotyping and cervical cancer screening using cervical cells collected by swab, TCT or LCT. This test utilizes Polymerase Chain Reaction (PCR) for DNA amplification and nucleic acid hybridization for the detection of high-risk HPV types in one reaction. This test specifically identifies 14 high-risk HPV types, including HPV-16, HPV-18, HPV-31, HPV-33, HPV-35, HPV-39, HPV-45, HPV-51, HPV-52, HPV-56, HPV-58, HPV-59, HPV-66, and HPV-68.
MTB DNA Extraction Kit (for the Sanity 2.0) utilizes magnetic particle technology for automated isolation and purification of nucleic acid from sputum sample, Tuberculosis cultured sample, Bronchial washing fluid, Bronchoalveolar lavage fluid (BALF) sample etc.
The Mycobacteria Identification Kit (Sanity 2.0) (Abbreviation: Sanity Myco) is a cartridge-based test kit for identifying 19 clinically relevant mycobacteria (including M. tuberculosis complex, M. chelonae, M. scrofulaceum, M. bovis, M. smegmatis, M. abscessus, M. kansasii, M. gordonae, M. lentiflavum, M. simiae, M. nonchromogenicum, M. terrae, M. marinum/M. ulcerans, M. fortuitum, M. avium, M. intracellulare, M. xenopi, M. malmoense and M. szulgai) from sputum samples.
The MDR-TB Test Kit (Sanity 2.0) (Abbreviation: Sanity MDR-TB) is a cartridge-based test kit for detecting multidrug-resistance mutations (including rifampin-resistant mutations and isoniazid-resistant mutations) in Mycobacterium tuberculosis (MTB) from sputum samples.
The Sanity 2.0 Respiratory Pathogen Panel is a multiplex real-time, reverse transcriptase polymerase chain reaction (RT-PCR) test intended for the in vitro qualitative detection and differentiation of influenza A, influenza B, respiratory syncytial virus (RSV) viral RNA in nasopharyngeal swab (NPS), oropharyngeal swab (OPS) and sputum specimens obtained from individuals suspected of respiratory tract infections.
This kit is used for in vitro qualitative detection of novel coronavirus (SARS-CoV-2) ORF1ab and N gene in specimens, including nasopharyngeal swab, oropharyngeal swab, saliva, sputum, bronchoalveolar lavage fluid, for diagnosis of the COVID-19 infection, the suspected cluster cases and of the patients who need differential diagnosis of COVID-19 infection.